These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 9568072
1. Impaired in vivo tumor growth of human pancreatic carcinoma cells retrovirally transduced with GM-CSF gene. Kimura M, Tagawa M, Yoshida Y, Takenouchi T, Takenaga K, Azuma K, Yamaguchi T, Saisho H, Sakiyama S. Anticancer Res; 1998; 18(1A):165-70. PubMed ID: 9568072 [Abstract] [Full Text] [Related]
2. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells. Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N. J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497 [Abstract] [Full Text] [Related]
4. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Gutschalk CM, Herold-Mende CC, Fusenig NE, Mueller MM. Cancer Res; 2006 Aug 15; 66(16):8026-36. PubMed ID: 16912178 [Abstract] [Full Text] [Related]
8. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene. Yoshida Y, Tasaki K, Miyauchi M, Narita M, Takenaga K, Yamamoto H, Yaaguchi T, Saisho H, Sakiyama S, Tagawa M. Cancer Gene Ther; 2000 Feb 15; 7(2):324-31. PubMed ID: 10770643 [Abstract] [Full Text] [Related]
10. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma. Sandler AD, Chihara H, Kobayashi G, Zhu X, Miller MA, Scott DL, Krieg AM. Cancer Res; 2003 Jan 15; 63(2):394-9. PubMed ID: 12543793 [Abstract] [Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF. Shi FS, Weber S, Gan J, Rakhmilevich AL, Mahvi DM. Cancer Gene Ther; 1999 Jan 15; 6(1):81-8. PubMed ID: 10078967 [Abstract] [Full Text] [Related]
12. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1. Tseng SH, Chen Y, Chang CJ, Tai KF, Lin SM, Hwang LH. Clin Cancer Res; 2005 Feb 15; 11(4):1639-49. PubMed ID: 15746069 [Abstract] [Full Text] [Related]
13. Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells. Yoshida Y, Tasaki K, Kimurai M, Takenaga K, Yamamoto H, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M. Anticancer Res; 1998 Feb 15; 18(1A):333-5. PubMed ID: 9568099 [Abstract] [Full Text] [Related]
14. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model. Chi CH, Wang YS, Lai YS, Chi KH. Anticancer Res; 2003 Feb 15; 23(1A):315-21. PubMed ID: 12680230 [Abstract] [Full Text] [Related]
20. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity. Wang L, Qi X, Sun Y, Liang L, Ju D. Cancer Gene Ther; 2002 Oct 15; 9(10):819-24. PubMed ID: 12224022 [Abstract] [Full Text] [Related] Page: [Next] [New Search]